Histological indicators of prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved survival.
about
Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26)Primary brain tumors, neural stem cell, and brain tumor cancer cells: where is the link?Prognostic implication of histological oligodendroglial tumor component: clinicopathological analysis of 111 cases of malignant gliomas.Quantitative susceptibility mapping differentiates between blood depositions and calcifications in patients with glioblastoma.Bevacizumab-induced tumor calcifications as a surrogate marker of outcome in patients with glioblastoma.Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups.Primary glioblastoma with oligodendroglial differentiation has better clinical outcome but no difference in common biological markers compared with other types of glioblastoma.E2F1 coregulates cell cycle genes and chromatin components during the transition of oligodendrocyte progenitors from proliferation to differentiation.Glioblastoma with oligodendroglial component represents a subgroup of glioblastoma with high prevalence of IDH1 mutation and association with younger age.Glioblastomas with oligodendroglial component have the same clinical phenotype as classical glioblastomas.Genetic aberrations in gliomatosis cerebri.Differential molecular genetic analysis in glioblastoma multiforme of long- and short-term survivors: a clinical study in Chinese patients.Dynamic study of methionine positron emission tomography in patients with glioblastoma with oligodendroglial components.Correlation among pathology, genotype, and patient outcomes in glioblastoma.Molecular and clinical analysis of glioblastoma with an oligodendroglial component (GBMO).Immunohistochemical evaluation of O6 -methylguanine DNA methyltransferase (MGMT) expression in 117 cases of glioblastoma.Glioblastomas with oligodendroglial component-common origin of the different histological parts and genetic subclassification.
P2860
Q33260758-3E79C41F-F102-42FD-9F8E-7A1433871DBAQ33729734-2440A01B-4B77-4BC7-93CB-5BAEDE3B0BD4Q34388126-C5D8F141-4E33-4EB4-9188-7EEB3A3BB44AQ34650241-27A72251-F624-47A6-BE78-E771A6FDA3DAQ35170377-E85201FB-9362-4640-97C8-B0A3532F7824Q36457608-0CA3A1E7-BCFF-4D92-BA14-04C635EE1484Q37312716-43E7EE67-F822-436E-961F-53A7BF36F1FAQ37502539-0B62F35D-B3D6-4883-9459-FC5108D9CDD1Q44293216-F839643E-6046-4A52-B962-265BCA3B8606Q44435988-FC57EDCA-5F06-42E5-8957-3FFF9FF65604Q46067711-11D6721C-F629-44CA-B3AC-4391D330BC58Q48125202-6EFE52F1-A46E-4D71-BD10-F524301925B4Q48261392-AD7F57AE-F8DB-4B23-85D2-7C803E6EF125Q48427408-ADC69ADE-23C8-4C8C-AEE8-1471B5803EBCQ54586063-67254D5B-036B-4CEA-A04C-EBEBB1E784F3Q55461295-596103C4-5045-40F9-B118-6EFD71B9DB70Q55463121-E89AA7D8-59AC-4D35-B461-35AE411C5A02
P2860
Histological indicators of prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved survival.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Histological indicators of pro ...... on indicate improved survival.
@en
Histological indicators of pro ...... on indicate improved survival.
@nl
type
label
Histological indicators of pro ...... on indicate improved survival.
@en
Histological indicators of pro ...... on indicate improved survival.
@nl
prefLabel
Histological indicators of pro ...... on indicate improved survival.
@en
Histological indicators of pro ...... on indicate improved survival.
@nl
P2093
P2860
P1433
P1476
Histological indicators of pro ...... on indicate improved survival.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2559.2004.01887.X
P577
2004-06-01T00:00:00Z